See All Slides - tctmd.com

Slides

Presentation TCT 2015

OCT Imaging Integration and Emerging Applications 1: FD-OCT Imaging and Endothelial Shear Stress Computation

Presenter: Gary S. Mintz, Guillermo Tearney, Peter H. Stone

October 15, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Martin W Bergmann

October 15, 2015

Presentation TCT 2015

OCT Technological Trends 2: Heart-Beat OCT Micro Motor System Technology

Presenter: Gary S. Mintz, Guillermo Tearney, Antonius F.W. van der Steen

October 15, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Brij Maini

October 15, 2015

Presentation TCT 2015

OCT Technological Trends 1: Two-Photon Luminescent-OCT Catheter System

Presenter: Gary S. Mintz, Guillermo Tearney, Marc D. Feldman

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Olaf Franzen

October 15, 2015

Presentation TCT 2015

Miscellaneous Emerging Technologies 4: Stent-Based Pulmonary Vein Isolation Approach to Atrial Fibrillation

Presenter: Greg L. Kaluza, Joachim Schofer, Glenn Van Langenhove

October 15, 2015

Presentation TCT 2015

Severe AS + Symptoms in an 80-Year-Old With Low Surgical Risk: TAVR or Surgery?

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Axel Linke

October 15, 2015

Presentation TCT 2015

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

Presenter: Greg L. Kaluza, Joachim Schofer, Miriam Silaschi

October 15, 2015

Advertisement

Slides

OCT Imaging Integration and Emerging Applications 1: FD-OCT Imaging and Endothelial Shear Stress Computation

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

OCT Technological Trends 2: Heart-Beat OCT Micro Motor System Technology

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

OCT Technological Trends 1: Two-Photon Luminescent-OCT Catheter System

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

Miscellaneous Emerging Technologies 4: Stent-Based Pulmonary Vein Isolation Approach to Atrial Fibrillation

Severe AS + Symptoms in an 80-Year-Old With Low Surgical Risk: TAVR or Surgery?

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content